198 related articles for article (PubMed ID: 20059716)
1. High efficacy of disopyramide in the management of ventricular fibrillation storms in a patient with Brugada syndrome.
Sumi S; Maruyama S; Shiga Y; Kodama S; Miyoshi K; Tojou H; Yamanouchi Y; Urata H
Pacing Clin Electrophysiol; 2010 Jun; 33(6):e53-6. PubMed ID: 20059716
[TBL] [Abstract][Full Text] [Related]
2. Arrhythmic storm responsive to quinidine in a patient with Brugada syndrome and vasovagal syncope.
Márquez MF; Rivera J; Hermosillo AG; Iturralde P; Colín L; Moragrega JL; Cárdenas M
Pacing Clin Electrophysiol; 2005 Aug; 28(8):870-3. PubMed ID: 16105018
[TBL] [Abstract][Full Text] [Related]
3. Electrical storm in Brugada syndrome successfully treated with orciprenaline; effect of low-dose quinidine on the electrocardiogram.
Kyriazis K; Bahlmann E; van der Schalk H; Kuck KH
Europace; 2009 May; 11(5):665-6. PubMed ID: 19346290
[TBL] [Abstract][Full Text] [Related]
4. Excellent long-term reproducibility of the electrophysiologic efficacy of quinidine in patients with idiopathic ventricular fibrillation and Brugada syndrome.
Belhassen B; Glick A; Viskin S
Pacing Clin Electrophysiol; 2009 Mar; 32(3):294-301. PubMed ID: 19272057
[TBL] [Abstract][Full Text] [Related]
5. Effects of low-dose quinidine on ventricular tachyarrhythmias in patients with Brugada syndrome: low-dose quinidine therapy as an adjunctive treatment.
Mizusawa Y; Sakurada H; Nishizaki M; Hiraoka M
J Cardiovasc Pharmacol; 2006 Mar; 47(3):359-64. PubMed ID: 16633076
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of quinidine in high-risk patients with Brugada syndrome.
Belhassen B; Glick A; Viskin S
Circulation; 2004 Sep; 110(13):1731-7. PubMed ID: 15381640
[TBL] [Abstract][Full Text] [Related]
7. A phenotypic combination of idiopathic VF and Brugada syndrome.
Martinek M; Purerfellner H
Pacing Clin Electrophysiol; 2010 Sep; 33(9):e84-7. PubMed ID: 20230473
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of asymptomatic Brugada patients with inducible ventricular fibrillation under hydroquinidine.
Bouzeman A; Traulle S; Messali A; Extramiana F; Denjoy I; Narayanan K; Marijon E; Hermida JS; Leenhardt A
Europace; 2014 Apr; 16(4):572-7. PubMed ID: 24068450
[TBL] [Abstract][Full Text] [Related]
9. Management of Brugada Syndrome: Thirty-Three-Year Experience Using Electrophysiologically Guided Therapy With Class 1A Antiarrhythmic Drugs.
Belhassen B; Rahkovich M; Michowitz Y; Glick A; Viskin S
Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1393-402. PubMed ID: 26354972
[TBL] [Abstract][Full Text] [Related]
10. Electrical storm in idiopathic ventricular fibrillation is associated with early repolarization.
Aizawa Y; Chinushi M; Hasegawa K; Naiki N; Horie M; Kaneko Y; Kurabayashi M; Ito S; Imaizumi T; Aizawa Y; Takatsuki S; Joo K; Sato M; Ebe K; Hosaka Y; Haissaguerre M; Fukuda K
J Am Coll Cardiol; 2013 Sep; 62(11):1015-9. PubMed ID: 23747791
[TBL] [Abstract][Full Text] [Related]
11. Elimination of late potentials by quinidine in a patient with Brugada syndrome.
Watanabe H; Chinushi M; Osaki A; Okamura K; Izumi D; Komura S; Hosaka Y; Tanabe Y; Furushima H; Washizuka T; Aizawa Y
J Electrocardiol; 2006 Jan; 39(1):63-6. PubMed ID: 16387054
[TBL] [Abstract][Full Text] [Related]
12. Successful use of quinidine in treatment of electrical storm in Brugada syndrome.
Mok NS; Chan NY; Chiu AC
Pacing Clin Electrophysiol; 2004 Jun; 27(6 Pt 1):821-3. PubMed ID: 15189543
[TBL] [Abstract][Full Text] [Related]
13. Quinidine: a valuable medication joins the list of 'endangered species'.
Viskin S; Antzelevitch C; Márquez MF; Belhassen B
Europace; 2007 Dec; 9(12):1105-6. PubMed ID: 17761793
[No Abstract] [Full Text] [Related]
14. Successful treatment of electrical storm with oral quinidine in Brugada syndrome.
Bettiol K; Gianfranchi L; Scarfò S; Pacchioni F; Pedaci M; Alboni P
Ital Heart J; 2005 Jul; 6(7):601-2. PubMed ID: 16274024
[TBL] [Abstract][Full Text] [Related]
15. Outcome after implantation of cardioverter defibrillator [corrected] in patients with Brugada syndrome: a multicenter Israeli study (ISRABRU).
Rosso R; Glick A; Glikson M; Wagshal A; Swissa M; Rosenhek S; Shetboun I; Khalamizer V; Fuchs T; Boulos M; Geist M; Strasberg B; Ilan M; Belhassen B;
Isr Med Assoc J; 2008 Jun; 10(6):435-9. PubMed ID: 18669142
[TBL] [Abstract][Full Text] [Related]
16. Near fatal ventricular fibrillation in Brugada syndrome despite presence of an implanted implantable cardioverter defibrillator.
Belhassen B; Viskin S
Can J Cardiol; 2014 Nov; 30(11):1460.e3-5. PubMed ID: 25240706
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of J wave-associated idiopathic ventricular fibrillation: role of drugs.
Chinushi M; Hasegawa K; Iijima K; Furushima H; Izumi D; Sato A; Aizawa Y
Pacing Clin Electrophysiol; 2012 Aug; 35(8):e226-30. PubMed ID: 21418245
[TBL] [Abstract][Full Text] [Related]
18. Brugada syndrome in children: don't ask, don't tell?
Viskin S
Circulation; 2007 Apr; 115(15):1970-2. PubMed ID: 17438161
[No Abstract] [Full Text] [Related]
19. The QUIDAM study: Hydroquinidine therapy for the management of Brugada syndrome patients at high arrhythmic risk.
Andorin A; Gourraud JB; Mansourati J; Fouchard S; le Marec H; Maury P; Mabo P; Hermida JS; Deharo JC; Delasalle B; Esnault S; Sadoul N; Davy JM; Leenhardt A; Klug D; Defaye P; Babuty D; Sacher F; Probst V
Heart Rhythm; 2017 Aug; 14(8):1147-1154. PubMed ID: 28411139
[TBL] [Abstract][Full Text] [Related]
20. Refractoriness to subcutaneous implantable cardioverter defibrillator after frequent therapies for ventricular fibrillation storms in a Brugada syndrome case.
Nakao Y; Suenari K; Yamashiro K; Nakagawa H; Shiode N
BMC Cardiovasc Disord; 2020 Mar; 20(1):134. PubMed ID: 32169057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
